Triple Negative Breast Cancer Treatment Options and Limitations: Future Outlook is a research paper published in Pharmaceutics (2023). On theSindex it has a DataRank of 0. It has been cited 421 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NIH/NIGMS
Grant: #1 R16GM145483-01
NIH/NIGMS
Grant: #1 C06 RR 020608-01
NIH/NIGMS
Grant: #1 C06 RR 14469-01
NIGMS NIH HHS
Grant: R16 GM145483
NIH/NIGMS
Grant: Grant # 1 R16GM145483-01
NCRR/NIH
Grant: Grants #1C06 RR 020608-01 and #1 C06 RR 14469-01.
National Institutes of Health
Grant: 1C06RR014469-01
RENOVATION THIRD FLOOR CHAUNCEY I. COOPER HALL-PHARMACY
National Institutes of Health
Grant: 1C06RR020608-01
EXTRAMURAL RESEARCH FACILITIES IMPROVEMENT PROGRAM: REN*: PHARMACOLOGY
National Institutes of Health
Grant: 1R16GM145483-01
Multifunctional Nanotechnology Platform for Triple Negative Breast Cancer Treatment
FWCI
70.74
Citation Percentile
1.0%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals